DRG Epidemiology’s coverage of heart failure (HF) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed event rates of AHF and the diagnosed prevalence for CHF for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan and 10 years for the other countries covered in this report.
All forecast data are available on Clarivate’s Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
DRG Epidemiology’s HF forecast will answer the following questions:
In developing countries, what impact will economic growth and development have on the number of people diagnosed with severe disease?
Of all AHF hospitalization events, how many in each of the major mature pharmaceutical markets are drug-treated?
Of all people diagnosed with CHF, how many in each of the major mature pharmaceutical markets are drug-treated?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of HF over the forecast period?
In addition to the total number of cases for each forecast year, Clarivate Epidemiology provides at least ten years of forecast data for the following HF subpopulations:
Diagnosed prevalent cases of CHF by NYHA functional class.
Diagnosed prevalent cases of CHF by treatment status.
Sunali D. Goonesekera, S.M., Senior Manager, Epidemiology. Prior to joining Clarivate, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.